Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer

Roelien van de Vrie, Hannah S. van Meurs, Marianne J. Rutten, Christiana A. Naaktgeboren, Brent C. Opmeer, Katja N. Gaarenstroom, Toon van Gorp, Henk G. Ter Brugge, Ward Hofhuis, Henk W. R. Schreuder, Henriette J. G. Arts, Petra L. M. Zusterzeel, Johanna M. A. Pijnenborg, Maarten van Haaften, Mirjam J. A. Engelen, Erik A. Boss, M. Caroline Vos, Kees G. Gerestein, Eltjo M. J. Schutter, Gemma G. KenterPatrick M. M. Bossuyt, Ben Willem Mol, Marrije R. Buist*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)449-456
Number of pages8
JournalGynecologic Oncology
Volume146
Issue number3
DOIs
Publication statusPublished - Sep 2017

Keywords

  • Cost-effectiveness
  • Ovarian cancer
  • Diagnostic laparoscopy
  • Cytoreductive surgery
  • Quality of life
  • PRIMARY DEBULKING SURGERY
  • QUALITY-OF-LIFE
  • NEOADJUVANT CHEMOTHERAPY
  • PHASE-III
  • TRIALS
  • ONCOLOGY
  • PREDICTION

Cite this

van de Vrie, R., van Meurs, H. S., Rutten, M. J., Naaktgeboren, C. A., Opmeer, B. C., Gaarenstroom, K. N., van Gorp, T., Ter Brugge, H. G., Hofhuis, W., Schreuder, H. W. R., Arts, H. J. G., Zusterzeel, P. L. M., Pijnenborg, J. M. A., van Haaften, M., Engelen, M. J. A., Boss, E. A., Vos, M. C., Gerestein, K. G., Schutter, E. M. J., ... Buist, M. R. (2017). Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer. Gynecologic Oncology, 146(3), 449-456. https://doi.org/10.1016/j.ygyno.2017.06.019